Lichterfeld, Mathias D., M.D.

Lab Info:

Principal Investigator: Lichterfeld, Mathias D., M.D.

Lab Staff:
3 post docs
1 bioinformatician
1 PhD student
4 technicians
1 undergraduate researcher
openings: postdoctoral fellow (

Office/Location: 65 Landsdowne St.

Phone: (617) 724-6454


Category: Members, Ragon Members

Dr. Mathias Lichterfeld is an infectious disease physician who works as a basic science and translational investigator, a clinical care provider, and a mentor and educator for residents and clinical/research fellows. Dr. Lichterfeld is an Associate Professor of Medicine at Harvard Medical School and Co-Director of the Harvard University Center for AIDS Research (CFAR) Program on HIV Eradication. He is also a staff physician in the Infectious Disease Division of Brigham and Women’s Hospital (BWH) and MGH; an Associate Member of the Ragon Institute of MGH, MIT and Harvard; and an Associate Member of the Broad Institute of MIT and Harvard.


Dr. Lichterfeld’s work focuses on three major areas of investigation:


1. Clinical trials related to HIV-1 cure and eradication: Dr. Lichterfeld serves a principal investigator of NIH-funded clinical trials aimed at reducing and eradicating HIV-1 reservoir cells.


2. Development of next-generation sequencing assays for deep profiling of HIV-1 reservoir cells. These activities focus on a multi-dimensional analysis platform to investigate the biophysical properties of viral reservoir cells.


3. Pediatric and neonatal HIV-1 infection: In collaboration with investigators from the Harvard T. H. Chan School of Public Health and the Botswana-Harvard Partnership Program, Dr. Lichterfeld conducts a research program to evaluate viral reservoirs and immune responses in HIV-1-infected neonates from Botswana and contributes to clinical trials aiming at remission and cure of pediatric HIV-1 infection.


Lichterfeld was named a fellow of the Infectious Disease Society of America (FIDSA) and elected a member of the American Society for Clinical Investigation (ASCI) in 2015. He is also a permanent member of the HIV Immunopathogenesis and Vaccine Development (HIVD) study section at the NIH Center for Scientific Review.


Dr. Lichterfeld received an MD and PhD from the University of Heidelberg, Germany. He completed training in internal medicine at MGH and subspecialty training in infectious diseases at MGH and BWH.



Unlocking the Secrets of HIV’s Persistence – BWH Clinical & Research News

Understanding HIV’s Persistence – Eurek Alert (AAAS) Article

Protein That Helps Battle HIV – Harvard Gazette Article

Discovering Where HIV Persists In Spite Of Treatment – Harvard Gazette Article

MGH/Ragon Institute study finds how protein blocks HIV life cycle in elite controllers – MGH News Releases


Major Recent Publications


1. Einkauf K, Lee GQ, Gao C, Sharaf R, Sun X, Hua s, Chen S, Jiang C, Lian X, Chowdhury FZ, Rosenberg ES, Chun TW, Li JZ, Yu XG, Lichterfeld M. Accumulation of intact HIV-1 proviruses with distinct chromosomal positions during long-term antiretroviral therapy. J Clin Invest 2019, 129:988-998.


2. Kuo HH, Ahmad R, Lee GQ, Chen HR, Ouyang Z, Szucs MJ, Kim D, Tsibris A, Chun TW, Battivelli E, Verdin E, Rosenberg ES, Carr S, Yu XG, Lichterfeld M. Anti-apoptotic protein BIRC5 maintains survival of HIV-1 infected CD4 T cells. Immunity 2018, 48:1183-1194


3. Orlova-Fink N, Chowdhury FZ, Sun X, Harrington S, Rosenberg ES, Yu XG, Lichterfeld M. Preferential susceptibility of Th9 and Th2 CD4 T cells to X4-tropic HIV-1 infection. AIDS 2017 Oct 23;31(16):2211-2215.


4. Lee GQ, Orlova-Fink N, Einkauf K, Chowdhury FZ, Sun X, Harrington S, Kuo HH, Hua S, Chen HR, Ouyang Z, Reddy K, Dong K, Ndung’u T, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M. Clonal expansion of genome-intact HIV-1 in functionally-polarized Th1 CD4 T cells. J Clin Invest 2017, 127:2689-2696.


5. Olesen R, Vigano S, Rasmussen T, Søgaard OS, Ouyang Z, Buzon M, Bashirova A, Carrington M, Palmer S, Brinkmann CR, Yu XG, Østergaard L, Tolstrup M, Lichterfeld M. Innate immune activity correlates with CD4 T cell-associated HIV-1 DNA decline during latency-reversing treatment with panobinostat. J Virol 2015 Oct 15;89(20):10176-89.


6. Sun H, Kim D, Li X, Kiselinova M, Ouyang Z, Vanderkerckhofe L, Shang H, Rosenberg ES, Yu XG, Lichterfeld M. Th1/17 polarization of CD4 T cells supports HIV-1 DNA persistence during  antiretroviral therapy. J Virol 2015 Sep 2. pii: JVI.01595-15.


7. Ouyang Z, Buzon MJ, Zheng L, Sun H, Yu XG, Bosch R, Mellors JW, Eron JJ, Gandhi RT, Lichterfeld M. Transcriptional Changes in CD8+ T cells during Antiretroviral Therapy Intensified with Raltegravir. Open Forum Infect Dis 2015 Apr 1;2(2):ofv045.


8. Leng J, Ho HP, Buzon M, Pereyra F, Walker BD, Yu XG, Chang E, Lichterfeld M. A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4 T cells from elite controllers. Cell Host & Microbe 2014, 15:717-28.


9. Buzon MJ, Pereyra F, Martin-Gayo E, Ouyang Z, Sun H, Li JZ, Piovoso M, Shaw A, Dalmau J, Zangger N, Martinez-Picado J, Zurakowski R, Yu XG, Telenti A, Walker BD, Rosenberg ES, Lichterfeld M. Long-term antiretroviral treatment initiated in primary HIV-1 infection affects the size, composition and decay kinetics of the reservoir of HIV-1 infected CD4 T cells. J Virol 2014, 88:10056-65.


10. Sun H, Buzon M, Shaw A, Karteebahn Berg R, Yu XG, Ferrando-Martinez S, Leal M, Ruiz-Mateos E, Lichterfeld M. Hepatitis C therapy with Interferon- and Ribavirin reduces CD4 T cell-associated HIV-1 DNA in HIV-1/HCV co-infected patients. J Infect Dis. 2014 May 1;209(9):1315-20. PMID:24277743.


11. Buzon M, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich T, Li J, Pereyra F, Zurakowski R, Walker B, Rosenberg E, Yu X, Lichterfeld M. HIV-1 persistence in CD4 T cells with stem cell-like properties. Nat Med 2014 Feb;20(2):139-42. PMID: 24412925.


12. Buzon, MJ, Yang, Y, Ouyang Z, Sun H, Seiss K, Rogich J, Le Gall S, Pereyra F, Rosenberg ES, Yu, XG, Lichterfeld M. Susceptibility to CD8 T cell-mediated killing influences the reservoir of latently HIV-1 infected CD4 T cells. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):1-9. PMID:23846565.


13. Yang Y, Al-Mozaini M, Buzon M, Beamon J, Ferrando-Martinez S, Ruiz-Mateos E, Rosenberg ES, Pereyra F, Yu XG, Lichterfeld M. CD4 T cell regeneration in HIV-1 elite controllers. AIDS. 2012 Mar 27;26(6):701-6. PMID: 22301416.


14. Vigneault F, Woods M, Buzon M, Li C, Pereyra F, Crosby SD, Rychert J, Church G, Martinez-Picado J, Rosenberg ES, Telenti A, Yu XG, Lichterfeld M. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol. 2011; 85:3015-9.


15. Chen H, Li C, Huang J, Cung T, Seiss K, Beamon J, Carrington MF, Porter L, Burke P, Ryan B, Weiss R, Cress W, Rosenberg ES, Walker BD, Yu XG, Lichterfeld M. CD4 T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 (waf-1/cip-1). J Clin Invest 2011; 121:1549-60.


16. Buzon MJ, Seiss K, Weiss R, Brass LB, Rosenberg ES, Pereyra F, Yu XG, Lichterfeld M. Inhibition of HIV-1 integration in ex vivo infected CD4 T cells from elite controllers. J Virol 2011; 85:9646-50.


17. Williams K, Seiss K, Beamon J, Pereyra F, Rosenberg ES, Walker BD, Yu XG, Lichterfeld M. Epigenetic regulation of telomerase expression in HIV-1-specific CD8+ T cells. AIDS. 2010;24:1964-6.


More publications

Current Members


Fatema (Navin) Chowdhury |

Navin joined Dr. Yu’s and Dr. Lichterfeld’s groups in August of 2014 as a Research Fellow. She received her PhD in Immunology at UT Southwestern Medical Center, where she studied how innate cytokines regulate CD8+ T cell function. She is interested in infectious diseases in the context of global health and in Xu’s lab she will study immune response to HIV-1. A native of Bangladesh, Navin grew up in the beautiful tea gardens of Srimongol and developed a love for the wilderness. She loves to travel around the world in search of culture and cuisine.


HK Photo Merge

Hsiaohsuan Kuo |

Hsiaohsuan joined Dr. Lichterfeld’s lab as Research Fellow in August 2015. She did her PhD research under the mentorship of Dr. William Baldwin at the Lerner Research Institute, where she studied the role of platelets and the complement system in vascularized organ transplant rejection. Hsiaohsuan is now studying host factors involved in HIV latency and establishment of the viral reservoir. Outside the lab, she loves attending music or literature related activities and exploring different places around the world.


Pilar Garcia Broncano |

Pilar received her PhD in 2017 at the Complutense University of Madrid, where she studied immune cell dysfunction and hyperactivation in HIV/HCV coinfected patients, as well as the in vitro and in vivo activity of nanoparticles against HIV-1 and HSV-2 infections to prevent their transmission in humans as a topical microbicide. She joined Dr. Yu’s and Dr. Lichterfeld’s labs in January 2016 as a visiting PhD student to study possible alterations in the HIV reservoir due to HCV treatment using HIV full genome sequencing in HIV/HCV coinfected patients. She returned to the lab in October 2016, as a Graduate Research Assistant while completing her PhD studies. She is currently a Research Fellow who is studying the immunological and virological characterization of HIV-1-infected patients who are taking antiretroviral therapy and various viral reactivation agents in several ongoing clinical trials. Pilar enjoys scuba diving, snowboarding, running and traveling in her free time.


Kevin Einkauf |

Kevin joined Dr. Yu’s and Dr. Lichterfeld’s labs as a Research Technician in June 2016 after receiving his B.A. in Neurobiology from Harvard College. In his undergraduate research, Kevin worked at McLean Hospital, studying the neural circuitry underlying depression and substance abuse. He also spent time as a research fellow at the Botswana-Harvard AIDS Institute Partnership in Gaborone, Botswana, studying HIV-1 drug resistance. Currently, Kevin is primarily focused on understanding the latent HIV-1 reservoir and how it responds to various clinical interventions. In his free time, Kevin enjoys hiking, traveling, and eating hot pot.


Ce (Charlie) Gao  |

Ce (Charlie) joined Dr. Yu’s and Dr. Lichterfeld’s labs in July 2017 as a Bioinformatics Specialist. He received his PhD in Bioengineering from Northeastern University and worked as a Postdoctoral Fellow at Beth Israel Deaconess Medical Center/Harvard Medical School, where he worked on cancer immunotherapy projects. He is currently collaborating with researchers in the lab on various projects related to HIV and ZIKA, including analyses regarding genomics, transcriptomics, and proteomics. In addition, he is responsible for the computational infrastructure of the lab. Outside the lab, he enjoys running, swimming, reading/listening to books, and watching movies.


Chenyang Jiang  |

Chenyang joined Dr. Yu ‘s and Dr. Lichterfeld’s labs as a Research Technician II and Lab Manager in August 2017 after graduating from the University of Connecticut with MS in Pathobiology. She received her BS in Biological Sciences in 2016 from Sichuan University in China. Previously, Chenyang focused her research on house dust mite-induced allergic airway disease in murine models of sickle cell disease. She switched from Pathobiology to Virology and Immunology work, and is now investigating possible alterations of HIV-1 viruses in HIV elite controllers and viremic controllers by doing full genome sequencing. In her free time, she enjoys traveling, reading, watching movies, and exploring Boston cuisine with friends.


Xiaodong Lian  |

Xiaodong joined Dr. Yu’s and Dr. Lichterfeld’s labs in September 2017 as a visiting PhD student. He is a graduate student from the Kunming Institute of Zoology, Chinese Academy of Sciences, where he studied MHC/HLA splicing variants and pig-tailed macaque animal models of HIV/AIDS. He currently works on understanding the viral reservoir in HIV controllers using viral genome sequencing. In his free time, Xiaodong enjoys watching movies, playing video games, hiking, and traveling with his friends.


Jane Blackmer  |

Jane joined Dr. Yu’s and Dr. Lichterfeld’s labs in June 2018 as a Research Technician after graduating from Tufts University. At Tufts, she received her B.S. in Biology while studying trinucleotide repeat instability and DNA double-strand break repair in Drosophila. Currently, she is interested in doing molecular virology work to understand the latent HIV-1 reservoir. Outside of lab, Jane enjoys music, reading, and spending time with friends and family.


Joshua Chevalier  |

Joshua joined Dr. Yu’s and Dr. Lichterfeld’s labs as a Research Technician in June 2018. He graduated from the University of Massachusetts Amherst with a B.S. in Biology, where he researched the replicative polymerases of the parasite Trypanosoma brucei. He has always been interested in studying infectious disease and will be analyzing the latent HIV-1 reservoir in HAART treated patients.  Outside of lab, Joshua enjoys exploring nature, traveling to new places, and spending time with friends.


Kyra Seiger |

Kyra joined Dr. Yu’s and Dr. Lichterfeld’s labs as a Research Technician in June 2019 after receiving her B.A. in Biology from Mount Holyoke College. During her undergraduate research, Kyra worked on a pre-clinical Chlamydia trachomatis vaccine trial and studied in vivo virulence factor gene expression during C. trachomatisinfection. She is currently interested in better understanding the latent HIV-1 reservoirs in HAART patients. Outside of lab, Kyra spends her time hiking, reading, chatting with friends, and trying every bakery in the Boston area.


Matt Osborn |

Matt joined Dr. Yu’s and Dr. Lichterfeld’s labs as a Research Technician in July 2019 after receiving his B.A. in Biochemistry and Physics and M.S. in Chemistry from the University of Pennsylvania. In his undergraduate research, he developed organs-on-chips to model heterogeneous tissues in human diseases. Matt is mainly working on sequencing and understanding the latent HIV-1 reservoir in patients undergoing ART. In his free time, he enjoys cooking, playing guitar, staying active, and trying to find quality cheap eats in Boston.


Yelizaveta (Liza)

Liza joined Dr. Yu’s lab as a Research Technician in July 2019 after graduating from Rutgers University. At Rutgers, she received her B.S. in Microbiology.  She did research on the microbial communities of Yellowstone National Park while focusing on bacterial and archaeal growth in mercury enriched hot springs to look for mercury resistance and mercury methylation. Currently, she is interested in immunology and virology while working on clinical trials that involve adult and infant patients that are HIV-1 reservoirs. Outside of lab, Liza spends her time reading, swimming, going to museums and aquariums, and watching documentaries.


Weiwei Sun |

Weiwei joined Dr. Yu’s and Dr. Lichterfeld’s labs as a Postdoctoral Research Fellow in September 2019. She received her PhD in Microbiology in 2017 and then worked as a Research Assistant for another two years at Institut Pasteur of Shanghai, Chinese Academy of Sciences, where she studied HIV and host interaction and the molecular mechanism of latent infection. She currently works on understanding the viral reservoir in HAART treated patients. In her free time, Weiwei enjoys watching movies, exploring Boston, and traveling with her friends.


Catherine Koofhethile |

Originally from Botswana, Dr. Catherine Koofhethile is a Postdoctoral fellow who recently joined Dr. Xu Yu and Dr. Mathias Lichterfeld’s lab in September 2019. She received her BSc in Medical Microbiology from the University of Surrey (UK) with the generosity of the Government of Botswana’s Ministry of Education Scholarship, and later completed a Masters’ degree in Immunology from the University of Birmingham (UK) as a self-sponsored student. Following her MSc, she spent a couple of years as a Graduate Research assistant at Oxford University (Goulder lab) where she was part of the team that characterized HIV specific immune responses in both B and C clade infected individuals. She completed her PhD in Immunology in 2016 at the HIV Pathogenesis Program (HPP), University of KwaZulu-Natal, South Africa with the generosity of the PhD scholarship she received from The Organization for Women in Science for the Developing World (OWSD). Her PhD project aimed to understand the factors that mediate virologic control and lack of control in individuals with HIV-1C infection in the absence of antiretroviral therapy (ART). She later joined the Essex lab at Harvard T. H. Chan School of Public Health (HSPH) as a postdoctoral/Fogarty fellow in 2017. She is currently working on a research project that is assessing the reservoir in HIV-1C infected adolescents from Botswana receiving long-term ART (>10 years). Catherine also holds a Research Associate position at Botswana Harvard AIDS Institute Partnership (BHP). Outside of work, Catherine is a Sunday School teacher, enjoys singing, traveling and is generally a lover of life.


Former Members

Sovanborey (Borey) Chea  |

Borey joined Dr. Lichterfeld’s lab in November 2018 as an undergraduate researcher. She is currently attending Harvard University, where she is studying Environmental Science and Public Policy with a Secondary in Chemistry. In the lab, she works on analyzing the latent HIV proviral reservoir in a cohort of HAART treated patients. In her free time, Borey likes watching the sunset, exploring new places, watching movies, and hanging out with friends.


Shivaali Maddali  |

Shivaali joined Dr. Yu’s and Dr. Lichterfeld’s labs in June 2017 as a Research Technician, Lab Manager, and Clinical Research Coordinator. She received her BS in Biomedical Engineering from Brown University, where she used 3D printing methods to develop biomimetic in vitro platforms to study cancer metastasis. Her current work utilizes flow cytometry to study peptide recognition in the context of the HIV-1 immune response. When not in the lab, Shivaali enjoys traveling, photography, watching football, playing soccer, and spending time with friends and family.


Carina Bannach  |

Carina joined Dr. Lichterfeld’s lab as a Graduate Research Assistant in October 2018 where she works on better characterizing the HIV reservoir. Concurrently, she is in the process of completing her PhD studies at Oxford Brookes University, UK, where she aims to understand gene expression in both lytic and persistent baculovirus infections. In her free time, Carina enjoys reading, traveling, and spending time with her family and friends.


Guinevere (Guin) Lee |

Guinevere (Guin) received her PhD in HIV genotypic drug resistance and tropism inferences from the University of British Columbia in Vancouver, Canada. She is fascinated by the intrahost genetic diversity of HIV, and dreams to understand more about its impact on clinical outcomes. She joined Dr. Lichterfeld’s lab in August 2015 as a Postdoctoral Fellow to study specifically HIV reservoir(s) in different immune cell types using HIV nucleotide sequence diversity as markers. When not in the lab, Guin enjoys scuba diving, traveling, creating music and audio processing. She is also a big fan of anime.



Naira Aleksanyan |

Naira joined the Dr. Yu and Dr. Lichterfeld’s lab in the 2016 as a research technician and clinical research coordinator. She received her BS in Biology from Suffolk University in Boston. In the past, Naira has investigated bacterial mating of Bacillus subtilis and Clostridium difficile attachment to intestinal cells. She is excited to switch from bacterial to viral work, and is currently learning to minimize killing PBMCs and infecting them with HIV. In her free time, Naira enjoys swimming, hiking, traveling, learning new idioms, and playing with goats.


Dhohyung‎ Kim

Dhohyung Kim |

Dhohyung Kim was a Research Fellow at the Ragon Institute. He received his PhD in Molecular, Cellular and Developmental Biology under the mentorship of Dr. Stefan Niewiesk, at the Ohio State University. In the Dr. Yu’s and Dr. Lichterfeld’s labs, Dhohyung studied the host cyclin-dependent kinases and HIV-1 reverse transcription, as well as the T cell intrinsic responses in various patient cohorts to HIV-1 infections. When not at work he enjoys traveling and driving around the city.


Sean Harrington

Sean Harrington |

Sean received his BS in Biochemistry from Northeastern University in December 2013. He joined Dr. Yu’s and Dr. Lichterfeld’s labs as a research technician and a lab manager in the spring of 2014, working to further understand the HIV-1 reservoir. When not in the lab, he enjoys going on runs around Boston and baking. Sean currently conducts cancer research at Bluebird Bio in Cambridge.



Samantha Tse |

Samantha is originally from Boston and received her BS in Biology at Boston College in the spring of 2014. She joined the Dr. Yu’s and Dr. Lichterfeld’s Labs shortly after in the summer of 2014 and is currently working as a Research Technician at the Ragon Institute with Dr. Dhohyung Kim studying systems biology in regards to elite controllers. When not in lab, she enjoys participating in adrenaline-inducing activities, such as rollercoasters, ziplining, and go-kart racing. She also enjoys hip hop dancing, karaoking, and hiking on long trails. Sammy is currently enrolled in a PhD/MD program at University of Massachusetts Medical School. She is interested in studying gut microbiome effects on the immune system.



 Almudena Torres-Cornejo |

Almudena has recently joined Dr. Lichterfeld’s Lab as a Postdoctoral Fellow. She obtained her Ph.D last September 2013 at the Biomedicine Research Institute of Seville, Virgen Del Rocio University Hospital, in Spain. During that period she was involved in both HIV and HCV viral infections, studying the role of plasma drugs’ concentrations, and host and viral genetic factors on the outcome of the standard HCV therapy. In addition, during last year she has been exclusively dedicated to the research of the HIV reservoir, and the impact of different treatment strategies on the replenishment of this cellular reservoir. Currently, at the Ragon Institute of MGH, MIT & Harvard, she will be focus on the study of different pharmaceutical and immunological strategies to reduce HIV-1 persistence. When not in the lab, she enjoys going to the beach (in summer), skiing (in winter) and exploring new places.



Maria J Buzon |

Maria is a postdoctoral fellow at the Ragon Institute. She obtained her Ph.D. in 2010 at the Institute of AIDS Research, Irsicaixa in Barcelona, Spain. This is where she first became interested in the HIV-1 reservoirs that persist despite HAART. After completion of her Ph.D. program and in order to increase the international dimension of her career, she subsequently joined the Ragon Institute as a postdoctoral fellow in Dr. Yu’s and Dr. Lichterfeld’s labs, where she has been working for almost 3 years in different projects related to viral persistence, including the characterization of the HIV-1 reservoir in patients treated during the early phase of the infection and the identification of cells with stem-cell like properties contributing to HIV-1 long-term persistence. Currently she is a recipient of the MGH ECOR Tosteson Postdoctoral Fellowship.


Jin Leng

Jin was a Research Fellow in the Lichterfeld lab at the Ragon Institute. He got his Ph.D. in Immunology from Cornell University in Ithaca, NY studying parasite immunology and later joined the lab in 2012. His research projects focused on the host cyclin-dependent kinases and HIV-1 reverse transcription, as well as the T cell intrinsic responses in various patient cohorts to HIV-1 infections.


Hong Sun

Hong joined the Lichterfeld lab as a visiting researcher in March 2012. She obtained her M.D. in China and received her Master’s Degree in Clinical Medicine. She is now a Ph.D. student at China Medical University. Her interests in the laboratory included strategies to eradicate HIV-1, with a focus on the HIV-1 reservoir in HAART-treated patients from acute or chronic phase infection. She found living in Boston amazing and she enjoyed exploring the city. Hong returned to China in May 2014 to finish her Ph.D.



Xiaodong Li

Xiaodong joined Dr. Lichterfeld’s Lab as a visiting student in August 2013. She is a graduate student in the Master’s/Ph.D. Combined Program at the Plant Virus Laboratory in Shenyang Agricultural University. She is from China and plans to learn the most cutting-edge virology techniques at the Ragon Institute. She has really enjoyed her first trip to the U.S. and found living in Boston wonderful. Xiaodong has returned to China to finish her PhD.


Amy Shaw

Amy received her BS in Microbiology and Immunology with a minor in Spanish from the University of Miami in 2012. She joined the Xu lab in early summer 2012, where she works as a research technician and as a lab manager in Dr. Yu’s and Dr. Lichterfeld’s labs. She currently works with Dr. Maria Buzon, conducting experiments to better understand the HIV-1 reservoir. When not at work, Amy enjoys going on nature walks with her dog, cooking new recipes, and going to Dave Matthews Band shows.